Cargando…
Clinical effectiveness of symptomatic therapy compared with standard step-up care for the treatment of low-impact psoriatic oligoarthritis: the two-arm parallel group randomised POISE feasibility study
INTRODUCTION: In psoriatic arthritis (PsA), treatment recommendations support first-line use of disease-modifying antirheumatic drugs (DMARDs). There are few treatment strategy trials, and no previous studies have investigated tailored treatment choice by disease severity. Studies in oligoarthritis...
Autores principales: | Rombach, Ines, Tucker, Laura, Tillett, William, Jadon, Deepak, Watson, Marion, Francis, Anne, Sinomati, Yvonne, Dutton, Susan J, Coates, Laura C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756359/ https://www.ncbi.nlm.nih.gov/pubmed/35035537 http://dx.doi.org/10.1177/1759720X211057668 |
Ejemplares similares
-
Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis—study protocol for the MONITOR-PsA study, a trials within cohorts study design
por: Rombach, Ines, et al.
Publicado: (2021) -
Erratum to “Clinical effectiveness of symptomatic therapy compared with standard step-up care for the treatment of low-impact psoriatic oligoarthritis: the two-arm parallel group randomised POISE feasibility study”
Publicado: (2022) -
Oligoarthritis Caused by Borrelia bavariensis, Austria, 2014
por: Markowicz, Mateusz, et al.
Publicado: (2015) -
Disseminated Blastomycosis Presenting as Oligoarthritis, Pneumonia, and Skin Disease in an Immunocompetent Child
por: Schildt, Emily, et al.
Publicado: (2021) -
P57 What are the outcomes of persistent oligoarthritis? A systematic review plan
por: Smith, Andrew, et al.
Publicado: (2022)